United Against Cancer: The UC Cancer Biology Retreat
On Nov. 8, the UC Department of Cancer Biology held its first all-day departmental retreat at the UC Reading Campus to discuss aspects of the cancer research being pursued by the various labs in the department.
The goal of the retreat was to share research ideas and strategies with the goal of translating basic science research into clinical progress in cancer treatment.
About 110 faculty members, affiliates (past department chairs, clinical research collaborators and investigators from Cincinnati Childrens Hospital Medical Center) and leaders including Interim Dean William Ball, MD; UC Cancer Institute Director William Barrett, MD; Cincinnati Cancer Center (CCC) Director Shuk-mei Ho, PhD; and CCC Governing Board Chair and pediatrics faculty member Arnie Strauss, MD, were in attendance.
Some highlights include:
- Department Chair Jun-Lin Guans outline of the department and its goals. Ball, Barrett and Ho delivered introductory talks as well.
- A keynote address from Yi Zheng, PhD, director of experimental hematology and cancer biology at Cincinnati Childrens, who described his strategies for "drugging the undruggable targets for cancer therapy and his argument that academic labs can identify lead chemotherapeutic compounds against targets deemed too difficult to tackle by pharmaceutical companies.
- A series of short talks from faculty, students and postdoctoral students. Graduate student Nick Brown from Susan Waltzs lab was presented the prize for "Best Presentation, titled, "The Ron Receptor as a Novel Mediator of Prostate Cancer Growth and Castration Resistance.
- A poster session where over 20 researchers presented their work.
- An impromptu address by Carrie Hayden, community advocate for cancer research, highlighting how patients benefit from the collective research efforts at UC.
"Ken Greis, PhD, and Susan Waltz, PhD, co-organizers and faculty members in the department, did a wonderful job organizing the retreat, says Guan, PhD, who is also a member of both the Cincinnati Cancer Center and UC Cancer Institute. "We truly appreciate all who attended and the encouraging words we received. I think that we had great interactions, and I look forward to the event next year as we further build up our cancer research strength and contribute to the UC Cancer Institute and Cincinnati Cancer Center goals.
"I was honored to attend and was invigorated by the depth and breadth of the cancer science initiatives so well presented, says Thomas Herzog, MD, clinical director of the UC Cancer Institute. "The event will continue to build the essential momentum for the cancer program at UC.
Second-Year Graduate Student Marissa Leonard (right) discusses a poster at the first annual Cancer Biology Retreat during the poster session.
Participants eat lunch at the first annual Cancer Biology Retreat, held on UC's Reading Campus.
Daniel Starczynowski, PhD, a faculty member within UC's department of pediatrics and a researcher at Cincinnati Children's, and other participants laugh at a joke during one of the presentations at the first annual UC Cancer Biology Retreat.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.